ACTL6A Is Co-Amplified with p63 in Squamous Cell Carcinoma to Drive YAP Activation, Regenerative Proliferation, and Poor Prognosis.

Cancer Cell
Authors
Abstract

Loss-of-function mutations in SWI/SNF chromatin-remodeling subunit genes are observed in many cancers, but an oncogenic role for SWI/SNF is not well established. Here, we reveal that ACTL6A, encoding an SWI/SNF subunit linked to stem cell and progenitor cell function, is frequently co-amplified and highly expressed together with the p53 family member p63 in head and neck squamous cell carcinoma (HNSCC). ACTL6A and p63 physically interact, cooperatively controlling a transcriptional program that promotes proliferation and suppresses differentiation, in part through activation of the Hippo-YAP pathway via regulators including WWC1. Ectopic ACTL6A/p63 expression promotes tumorigenesis, while ACTL6A expression and YAP activation are highly correlated in primary HNSCC and predict poor patient survival. Thus, ACTL6A and p63 collaborate as oncogenic drivers in HNSCC.

Year of Publication
2017
Journal
Cancer Cell
Volume
31
Issue
1
Pages
35-49
Date Published
2017 Jan 09
ISSN
1878-3686
DOI
10.1016/j.ccell.2016.12.001
PubMed ID
28041841
PubMed Central ID
PMC5225026
Links
Grant list
R01 DE015945 / DE / NIDCR NIH HHS / United States
R01 HL116756 / HL / NHLBI NIH HHS / United States